by Ian Scheffler, University of Pennsylvania Kidneys form as their tubules branch, a variable process that leads to some people’s kidneys having nine times as many nephrons as others — and potentially many more times the filtration power and lifespan. Credit: Bella Ciervo To Alex Hughes, Assistant Professor in Bioengineering within Penn Engineering and in Cell...
Tag: <span>Kidney disease</span>
Supplements Have a Role in Treating Kidney Disease, but Only Certain Ones
Brandy Winfree Root, RDN DISCLOSURES | August 28, 2024 The global dietary supplement industry generates more than $400 billion a year. Supplements are alleged to treat many health concerns, from immune conditions and cognition to sexual dysfunction and premature wrinkles. Although some supplements have been proven to be helpful, others have no scientific basis. I...
Genetic analysis sheds light on the role of IFT140 in polycystic kidney disease
September 10, 2024 by Tokyo Medical and Dental University Through a comprehensive genetic analysis of patients with PKD but no family history of the disease, researchers found that a mutation in the IFT140 gene was significantly prevalent. Compared to patients with mutations in more commonly affected genes, PKD in people with an IFT140 mutation usually...
Kidney disease medication found to reduce risk of cardiovascular death in certain heart failure patients in new study
By Jacqueline Howard, CNNPublished 6:00 AM EDT, Sun September 1, 2024 Few treatments are available for a type of heart failure that includes mildly reduced or preserved ejection fraction. simonkr/E+/Getty Images/File A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of...
Novo reports ‘really powerful’ cardio, death risk reduction for semaglutide in kidney disease
May 24, 2024 07:15 AM EDTUpdated 08:02 AM R&DPharma AUTHORKatherine LewinNews [email protected] Novo Nordisk’s semaglutide cut the risk of major cardiovascular events and death from multiple causes in a Phase 3 study involving patients with type 2 diabetes and chronic kidney disease, building the company’s case for expanding the drug in a broad range of...
Simple measurement can predict risk of worsening of widespread kidney disease
by Aarhus University Graphical Abstract. Credit: Nephrology Dialysis Transplantation (2024). DOI: 10.1093/ndt/gfad271About ten percent of the Danish population suffers from chronic kidney disease, and some individuals experience rapid deterioration after the diagnosis is made. Now, a team of researchers from Aarhus University in a comprehensive study has investigated the precise risk of rapid progression, and the...
Significant benefit seen in Phase III trial of experimental drug for kidney disease
by University of Washington School of Medicine Credit: Pixabay/CC0 Public Domain In a clinical trial of patients with chronic kidney disease, an experimental drug significantly reduced albuminuria—albumin in urine, a sign of kidney damage—for 50% of participants. When the experimental drug was paired with a standard-care medication, 70% of participants reportedly experienced a significant reduction in...
Guidance for prevention, diagnosis, evaluation, treatment of hepatitis C virus in chronic kidney disease
by American College of Physicians Credit: CC0 Public Domain The latest clinical practice guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) organization offers guidance for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) in chronic kidney disease (CKD). The guideline is a targeted update to 2018 recommendations on the same topic and...
Chronic kidney disease raises risk of sudden cardiac arrest among Hispanics and Latinos
By Anika NayakOct. 11, 2023 APSTOCKChronic kidney disease was the strongest risk factor for sudden cardiac arrest among Hispanic and Latino adults in the first study to evaluate this population in the U.S. for risk factors of this major cause of death. Researchers from Cedars–Sinai Medical Center in Los Angeles identified clinical predictors that influence...
Study confirms pioneering drug highly effective for rare kidney disease
by Newcastle University Credit: Pixabay/CC0 Public DomainA pioneering drug for a rare kidney disease prevents organ failure and significantly improves the outcome for patients, new research has confirmed. Atypical hemolytic uraemic syndrome (aHUS) is a genetic life-threatening condition caused by a defect in the immune system which leads to kidney failure. Newcastle University, UK, carried...